Pfizer says COVID-19 vaccine more than 90% effective in kids

Associated Press

Kid-size doses of Pfizer’s COVID-19 vaccine appear safe and nearly 91% effective at preventing symptomatic infections in 5- to 11-year-olds, according to study details released Friday as the U.S. considers opening vaccinations to that age group.

The shots could begin in early November, with the first children in line fully protected by Christmas, if regulators give the go-ahead. That would represent a major expansion of the nation’s vaccine drive, encompassing roughly 28 million elementary school-age youngsters.

Click the heart to favorite

Your feedback is crucial to telling Western's story.
Friday, October 22, 2021 - 11:54am